Home›People›Rob Hopfner
RH

Rob Hopfner

Director at Land Therapeutics Inc.

Director
Updated Nov 8, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About Rob Hopfner

Rob Hopfner is a director at Land Therapeutics, which develops affordable gene therapy for sickle cell disease.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Rob Hopfner in the role, so the role may have started earlier or lasted longer.

Land Therapeutics Inc. Current
Director
2025 – Present · Charlestown, MA
Land Therapeutics develops an affordable gene therapy delivered inside the body for sickle cell disease.

Key Colleagues at Startups

The people Rob Hopfner works with at each company, as listed on that company's latest Form D.

Land Therapeutics Inc. · Form D/A, Oct 21, 2026
TH
Tony Ho
CEO and director
TS
JC
Joe Cabral
Director
AM
Andy May
Director
DP
Dan Peer
Director

Sources

  1. SECLand Therapeutics Inc. Form D/A, filed Oct 21, 2026
  2. P2Evommune bio
  3. P3Plexium team profile
  4. P4Vaxcyte director biography
  5. P5Civitas director biography